Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 86 Schemes (27.01%)
Foreign Institutions
Held by 222 Foreign Institutions (10.29%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
44 Million
(Quarterly Results - Dec 2025)
Net Profit:
-99 Million
Pharmaceuticals & Biotechnology
USD 1,957 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.35
-999,999.00%
0.76






